Systematic Review of the Effects of Ginseng on Cardiovascular Risk Factors.
From: Division for Research and Education in Complementary and Integrative Medical Therapies, Harvard Medical School, Boston, MA 02215-3325, USA. catherine_buettner@hms.harvard.edu
The Annals of pharmacotherapy
- Publish Date: Jan 2006
- ISSN: 1060-0280
- Volume: 40
- Issue: 1
- Pages: 83-95
- Medium: Print
- Language: English
- Citation (JAMA): Buettner Catherine, Yeh Gloria Y, Phillips Russell S, et al. Systematic Review of the Effects of Ginseng on Cardiovascular Risk Factors.. Jan 2006;40:83-95
Abstract
OBJECTIVE: To examine the evidence for the efficacy of ginseng (Panax spp.) on cardiovascular risk factors, including blood pressure, lipid profiles, and blood glucose, and to summarize reported cardiovascular adverse events. DATA SOURCES: We searched MEDLINE, AMED, BIOSIS, CAB, EMBASE, and the Cochrane Controlled Trials databases through July 2005 and performed hand searches of bibliographies. STUDY SELECTION AND DATA EXTRACTION: Short- or long-term, randomized, controlled trials and nonrandomized studies published in English were included. Data were extracted in a standardized manner, and 2 independent investigators assessed methodologic quality of the studies. Thirty-four studies were identified with results for blood pressure, lipids, and/or blood glucose. Due to heterogeneity of the studies, we were unable to perform a meta-analysis. Data on cardiovascular adverse events were extracted from events reported in identified studies and from case reports. DATA SYNTHESIS: The majority of studies were short term. Ginseng may slightly decrease blood pressure compared with placebo (range 0-4%). We found mixed results for an effect on lipids, with 5 of 9 studies showing improvement in one or more lipid parameters compared with baseline (range 7-44%). We identified several studies showing that ginseng lowers blood glucose, but overall studies were inconsistent. CONCLUSIONS: Current evidence does not support the use of ginseng to treat cardiovascular risk factors. Some studies suggest a small reduction in blood pressure. Despite some evidence showing that ginseng lowers blood glucose and improves lipid profiles, well-designed, randomized, controlled trials evaluating its effects are lacking.
Mesh Headings (Keywords): Blood Glucose, Blood Pressure, Cardiovascular Diseases, Cholesterol, Humans, Panax, Plant Extracts, Randomized Controlled Trials as Topic, Risk Factors, Treatment Outcome
Check for Full Text / PubMed Unique Identifier (PMID): 16332943
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.